Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
The European Commission has granted marketing authorization under exceptional circumstances for NEZGLYAL® (leriglitazone) as the first pharmacological treatment for male cerebral adrenoleukodystrophy (cALD) patients aged 2 to 12 years with ... Read More
Continuous Coverage
Wasim El-Haj Sues NSW Government Over Keffiyeh Ban at Sydney Girls High School Wasim El-Haj, a Palestinian Australian…
Nicotine is mounting a comeback within the wellness movement, with advocates promoting it as a cognitive enhancer, stress-management…
Ahead of the Dallas Cowboys and Baltimore Ravens matchup at Maracanã Stadium in Rio de Janeiro, Brazil, viral…
Es Devlin is opening her first major UK retrospective, Es Devlin: Other Worlds, at the Design Museum in…
As the Indonesian commuter market moves toward lower operational expenditures in late September 2026, buyers seeking entry-level electric…
It sounds like an eccentric dispatch log from a quiet Nordic Sunday. But when livestock disrupts critical urban…
Global Affairs
Kevin Lewis, director of Willy’s Wonderland, returns with the holiday horror-comedy Christmas At The Kringles, written by Zack…
Markets And Money
Microsoft co-founder Bill Gates has broken from traditional tech industry resistance to government oversight, warning that advanced artificial…
Digital Culture
Researchers using advanced tensor tomography have uncovered the molecular architecture of the narwhal tusk, revealing a dual-helix structure…
Science And Wellbeing
Published in npj Aging by researchers from King’s College London, the NeuroFit randomized trial evaluated 52 healthy, sedentary…
Screen And Sound
As the Milan Fashion Week unfolds through September 28, 2026, street style outside the official spring-summer 2027 runway…
Fixtures And Form
All Elite Wrestling hosted All Out 2026 on September 26, 2026, live from the NOW Arena in Hoffman…
